P.363JEWELFISH: safety and pharmacodynamic data in patients with spinal muscular atrophy (SMA) receiving treatment with risdiplam (RG7916) that have previously been treated with nusinersen
| Autor: | Chiriboga, C., Mercuri, E., Fischer, D., Day, J., Kraus, D., Yeung, W., Kletzl, H., Gerber, M., Cleary, Y., Gorni, K. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2019 29 Supplement 1:S187-S187 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect